Diabetes Care, Vol 17, Issue 11 1247-1251, Copyright © 1994 by American Diabetes Association

ARTICLES

Prevalence of arterial hypertension in diabetic patients before and after the JNC-V

L Tarnow, P Rossing, MA Gall, FS Nielsen and HH Parving
Steno Diabetes Center, Gentofte, Denmark.

OBJECTIVE--To compare the prevalence of arterial hypertension in patients with insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) according to blood pressure (BP) criteria from the World Health Organization (WHO) and The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). RESEARCH DESIGN AND METHODS--Two cohorts of Caucasian patients attending the outpatient clinic at Hvidore Hospital were identified: 1) 957 patients with IDDM; 53% men, 40 (18-75) years of age (mean [range]); and 2) 549 patients with NIDDM; 53% men, 60 (20-76) years of age. BP was measured at least yearly, while patients rested in a sitting position, with a standard clinical sphygmomanometer. Patients were classified as hyper- or normotensive based on average BP during a 3-year follow-up period. Patients receiving antihypertensive treatment were classified as hypertensives. RESULTS--In IDDM patients, the prevalence of arterial hypertension rose from 15 to 42% in the normoalbuminuric group, from 26 to 52% in the microalbuminuric group, and from 61 to 79% in the macroalbuminuric group when WHO and JNC-V criteria were compared. The corresponding rises in NIDDM patients were from 51 to 71% (normo-), from 73 to 90% (micro-), and from 82 to 93% (macroalbuminuria). Of the untreated hypertensive patients, 78% of IDDM patients and 50% of NIDDM patients had stage 1 (140-159/90-99 mmHg) hypertension; 20% of IDDM patients and 37% of NIDDM patients had stage 2 (160-179/100-109 mmHg) hypertension. Two out of three untreated hypertensive patients had isolated systolic hypertension. CONCLUSIONS--The new JNC-V criteria approved by the American Diabetes Association leads to a considerable increase in the prevalence of arterial hypertension in a population of IDDM and NIDDM patients. Isolated systolic hypertension contributes importantly.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y.-L. He, M. Ligueros-Saylan, G. Sunkara, R. Sabo, C. Zhao, Y. Wang, J. Campestrini, F. Pommier, K. Dole, A. Marion, et al. Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects J. Clin. Pharmacol., January 1, 2008; 48(1): 85 - 95. [Abstract] [Full Text] [PDF]

				R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF]

				L. Cortigiani, R. Bigi, R. Sicari, P. Landi, F. Bovenzi, and E. Picano Prognostic Value of Pharmacological Stress Echocardiography in Diabetic and Nondiabetic Patients With Known or Suspected Coronary Artery Disease J. Am. Coll. Cardiol., February 7, 2006; 47(3): 605 - 610. [Abstract] [Full Text] [PDF]

				J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]

				C. E. Mogensen, G. Viberti, S. Halimi, E. Ritz, L. Ruilope, G. Jermendy, J. Widimsky, P. Sareli, J. Taton, J. Rull, et al. Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER Hypertension, May 1, 2003; 41(5): 1063 - 1071. [Abstract] [Full Text] [PDF]

				D. C Wheeler Protecting the kidneys and cardiovascular system in type 2 diabetes The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 77 - 79. [PDF]

				J. Ribstein, G. Du Cailar, and A. Zanchetti Cardiac and renal damage in the elderly hypertensive Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1_suppl): S16 - S24. [PDF]

				P. C. Deedwania Hypertension and Diabetes: New Therapeutic Options Arch Intern Med, June 12, 2000; 160(11): 1585 - 1594. [Abstract] [Full Text] [PDF]

				D. M. Lloyd-Jones, J. C. Evans, M. G. Larson, C. J. O'Donnell, P. W. F. Wilson, and D. Levy Cross-classification of JNC VI Blood Pressure Stages and Risk Groups in the Framingham Heart Study Arch Intern Med, October 11, 1999; 159(18): 2206 - 2212. [Abstract] [Full Text] [PDF]

				A. Tenenbaum, E. Z. Fisman, V. Boyko, U. Goldbourt, E. Graff, J. Shemesh, A. Shotan, H. Reicher-Reiss, S. Behar, and M. Motro Hypertension in Diet Versus Pharmacologically Treated Diabetics : Mortality Over a 5-Year Follow-Up Hypertension, April 1, 1999; 33(4): 1002 - 1007. [Abstract] [Full Text] [PDF]

				J. Hinson, K. Riordan, D. Hemphill, C. Randolph, and V. Fonseca Hypertension Education: An Important and Neglected Part of the Diabetes Education Curriculum? The Diabetes Educator, January 1, 1997; 23(2): 166 - 170. [PDF]